Cyclotraxin B
Cyclotraxin B (CTX-B) is a small (1200 Da) cyclic peptide and highly potent (IC 50 = 0.30 nM), selective, and non-competitive antagonist or negative allosteric modulator of TrkB, the main receptor of brain-derived neurotrophic factor…
≈ 2 min read
Cyclotraxin B. encyclopegia.org, snapshot enwiki-001329038706. /a/cyclotraxin-b
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Cyclotraxin B (CTX-B) is a small (1200 Da) cyclic peptide and highly potent (IC 50 = 0.30 nM), selective, and non-competitive antagonist or negative allosteric modulator of TrkB, the main receptor of brain-derived neurotrophic factor (BDNF). CTX-B was originally developed by Cazorla M. and colleagues at Université Paris and Inserm in 2010, mimicking a specific structural loop in BDNF known for its functional selectivity.
Cyclotraxin-B's name originates from Cyclic trk inhibitor B. CTX-B crosses the blood-brain-barrier with systemic administration and produces anxiolytic-like effects in animals, though notably not antidepressant-like effects. The compound has also been found to produce analgesic effects in animal models of neuropathic pain.
In addition to TrkB, CTX-B has been found to be an allosteric modulator of VEGFR2, one of the receptors of vascular endothelial growth factor (VEGF).
Text derived from https://en.wikipedia.org/w/index.php?oldid=1329038706 under CC BY-SA 4.0; modifications have been made.